A.   Increased urine specific gravity

B.   Relief of pain

C.   Increased serum albumin levels

D.   Decreased adrenocorticotropic hormone levels

A.   Thyroxine, Aldosterone, Thyrotropin-releasing hormone (TRH)

B.   Growth hormone (GH), Thyroid-stimulating hormone (TSH), Adrenocorticotropic hormone (ACTH)

C.   Thyroxine, Thyroid-stimulating hormone (TSH), Thyrotropin-releasing hormone (TRH)

D.   Adrenocorticotropic hormone (ACTH), Aldosterone, Thyrotropin-releasing hormone (TRH)

A.   Somatostatin

B.   Choriomammotropin

C.   Somatolactin

D.   Somatropin

A.   Oxytocin

B.   Vasopressin

C.   Octreotide

D.   Cosyntropin

A.   Acromegaly

B.   Polydipsia

C.   Hypopituitary dwarfism

D.   Polyuria

A.   Vasopressin

B.   Desmopressin

C.   Somatropin

D.   Luteinizing hormone

A.   Uric acid level

B.   Complete blood count result

C.   Blood glucose level

D.   Creatinine clearance test

A.   Cyclosporine

B.   Carbamazepine

C.   Ciprofloxacin

D.   Demeclocycline

A.   Oxytocin

B.   Cosyntropin

C.   Octreotide

D.   Thyroid hormone

A.   Polyuria

B.   Dehydration

C.   Headache

D.   Polydipsia

A.   Cosyntropin

B.   Somatropin

C.   Octreotide

D.   Desmopressin

A.   Desmopressin

B.   Somatropin

C.   Vasopressin

D.   Octreotide

A.   Produces an additive effect

B.   Reduces the effects of desmopressin

C.   Causes prolongation of QT interval

D.   Enhances the effects of desmopressin

A.   Hypotension

B.   Scar formation

C.   Edema

D.   Inflammation

A.   Malaise, Dyspnea,

B.   Arthralgia, Hypercalciuria, Constipation

C.   Constipation, Malaise, Hypercalciuria

D.   Dyspnea, Constipation, Hypercalciuria

A.   Liver enzyme levels, Renal function studies, Weight

B.   Liver enzyme levels, Blood glucose levels, Renal function studies

C.   Weight, Blood pressure, Blood glucose levels

D.   Renal function studies, Liver enzyme levels, Blood pressure

A.   Carbamazepine

B.   Norepinephrine

C.   Acetaminophen

D.   Thioridazine

A.   Improved tissue-building processes, Low blood sugar levels, Retention of potassium levels

B.   Low blood sugar levels, Increased lipid mobilization, Retention of potassium levels

C.   Low blood sugar levels, Retention of potassium levels, Increased retention of sodium

D.   Increased lipid mobilization, Increased retention of sodium, Improved tissue-building processes

A.   Reduces fat levels

B.   Reduces weight loss

C.   Decreases growth

D.   Decreases fluid retention

A.   Diabetes insipidus, Seizure, Type I von Willebrand

B.   Cardiovascular disease, Diabetes insipidus, Type I von Willebrand

C.   Seizure, Asthma, Cardiovascular disease

D.   Asthma, Diabetes insipidus, Type I von Willebrand

A.   Ciprofloxacin

B.   Glucocorticoids

C.   Fludrocortisone

D.   Cyclosporine

A.   Orthostatic hypotension

B.   Hypokalemia

C.   Hyponatremia

D.   Hyperglycemia

A.   Edema

B.   Seizures

C.   Heartburn

D.   Hypoglycemia

A.   Vasopressin and carbamazepine

B.   Vasopressin and demeclocycline

C.   Somatropin and glucocorticoids

D.   Desmopressin and carbamazepine

A.   An 8-year-old with a pituitary tumor

B.   A 7-year-old diagnosed with growth hormone deficiency

C.   A 17-year-old who is 5 feet tall

D.   A 10-year-old of short stature who has severe asthma

A.   Bilateral metastatic breast cancer

B.   Human immunodeficiency virus (HIV) infection

C.   Acute bronchitis with laryngitis

D.   Cachexia and closed growth plates

A.   Loss of consciousness

B.   Watery diarrhea

C.   Oozing blood

D.   Abundant, diluted urine

A.   "Shake the drug preparation thoroughly before use."

B.   "Inhale the drug preparation by spraying into the nostrils."

C.   "Dilute the drug preparation before administration."

D.   "Apply the drug preparation topically to the nasal membranes."

A.   Hypertension

B.   Hypercalciuria

C.   Hyperglycemia

D.   Hypothyroidism

A.   Pressing the pump once to spray a 10-mcg dose

B.   Priming the nasal pump once a week

C.   Replacing the cap on the pump after the procedure

D.   Pressing down on the pump two times to prime it

A.   Skin turgor, Height, Visual acuity

B.   Weight, Skin turgor, Visual acuity

C.   Height, Weight, Motor skills

D.   Motor skills, Visual acuity, Skin turgor

A.   "Is there any change in the color of your sputum?" "Do you have excessive bleeding due to minor injuries?"

B.   "Do you feel very thirsty lately?" "How many times do you urinate in a day?"

C.   "Do you have excessive bleeding due to minor injuries?" "Is there any change in the color of your urine?"

D.   "Is there any change in the color of your urine?" "Is there any change in the color of your sputum?"

A.   Inhaling the medication into the airway

B.   Storing the pump at room temperature

C.   Priming the pump each week

D.   Administering half the dose in each nostril

A.   The medication is not effective for this condition.

B.   A higher dose of medication is required for treatment.

C.   The patient needs to adjust fluid intake.

D.   The patient is stable and needs reassurance.

A.   Joint pain, Fatigue

B.   Fatigue, Headache

C.   Headache, Joint pain

D.   Diarrhea, Flushing

A.   Patient A: esophageal varices; type 1 diabetes

B.   Patient D: VIP; severe diarrhea and flushing; renal impairment

C.   Patient B: carcinoid tumor; taking ciprofloxacin

D.   Patient C: VIP; life-threatening hypotension; diarrhea and flushing

A.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Give half a spray in each nostril. 5. Replace the cap on the bottle. 6. Monitor the level of drug left in the pump.

B.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Replace the cap on the bottle. 5. Give half a spray in each nostril. 6. Monitor the level of drug left in the pump.

C.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Give half a spray in each nostril. 5. Monitor the level of drug left in the pump. 6. Replace the cap on the bottle.

D.   1. Clear the nasal passages. 2. Give half a spray in each nostril. 3. Place the spray nozzle in the nostril. 4. Prime the pump by pressing down four times. 5. Replace the cap on the bottle. 6. Monitor the level of drug left in the pump.

A.   Small-bowel fistula and having an acute asthma attack

B.   Carcinoid tumor-secreting vasoactive intestinal peptide (VIP)

C.   Acromegaly and a serum creatinine level of 5.0 mg/dL

D.   Esophageal varices and a history of type 2 diabetes

A.   Measure the patient’s urine output regularly.

B.   Assess for signs of dehydration.

C.   Watch the IV site closely for infiltration.

D.   Make a note of the fluid intake.

A.   Weight gain, Edema of the extremities

B.   Elevated blood pressure, Weight gain

C.   Increased urination, Thirst

D.   Edema of the extremities, Elevated blood pressure

A.   Notice increase in body temperature

B.   Monitor for signs of infiltration

C.   Inquire about abdominal discomfort

D.   Assess the patient for headaches

A.   Review current laboratory values for blood glucose

B.   Calculate the dosage with the pharmacist or another nurse

C.   Obtain baseline weight and height measurements

D.   Review the frequency with the health care provider

A.   Radiology report identifies no fracture with closed growth plates.

B.   Reports episodic muscle pain during the past year.

C.   Growth percentile has increased from the previous annual physical.

D.   Previous somatropin injection site tender to touch.

A.   Renal panel

B.   Electrocardiogram (ECG)

C.   Liver enzymes

D.   Blood glucose

A.   Octreotide subcutaneous

B.   Desmopressin intravenously

C.   Vasopressin nasal spray

D.   Somatropin intramuscular

A.   Nausea, Blood glucose elevation, Headache, Low blood pressure

B.   Nausea, Blood glucose elevation, Headache, Low urine output

C.   Low blood pressure, Blood glucose elevation, Headache, Low urine output

D.   Headache, Low urine output, Low blood pressure, Nausea

A.   Bleeding gums

B.   Limping

C.   Abdominal cramps

D.   Excessive thirst

A.   Administering the vasopressin intravenously

B.   Monitoring the patient in an intensive care unit

C.   Co-administering carbamazepine

D.   Obtaining liver and renal function tests

A.   Encourage vigorous exercise.

B.   Monitor blood glucose levels closely.

C.   Evaluate the patient for limping.

D.   Monitor fluid status.

A.   "Shake the medication before administration."

B.   "Heat the medicine before administration."

C.   "Do not administer the drug to the patient."

D.   "Keep the bottle in warm water before administration."

A.   Drowsiness

B.   Vertigo

C.   Abdominal stress

D.   Bleeding gums

A.   Somatropin

B.   Desmopressin

C.   Vasopressin

D.   Cosyntropin

A.   "If it is almost time for your next dose, take a double dose of the drug at that time."

B.   "Skip the missed dose and resume your usual dosage schedule."

C.   "You can take the dose immediately when you remember it."

D.   "You should consult your primary health care provider immediately."

A.   Octreotide

B.   Somatropin

C.   Vasopressin

D.   Desmopressin

A.   Octreotide

B.   Somatropin

C.   Desmopressin

D.   Corticotropin